Showing results (11-20 of 354) with videos related to
Sort By:
Pageof 36
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S EwerExpert Opinion on Drug Safety|August 13, 2013
Enigmas regarding the true extent and impact of tyrosine kinase inhibitor-related cardiotoxicityMichael S Ewer, Steven M EwerCancer|June 22, 2010
The integrity of authorship: doing the right thingRaphael E Pollock, Michael S EwerCancer Research|June 4, 2009
Cancer prevention: from 1727 to milestones of the past 100 yearsScott M Lippman, Ernest T HawkClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
The convergent development of molecular-targeted drugs for cancer treatment and preventionScott M Lippman, John V HeymachCell Metabolism|September 17, 2020
Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound HealingRonald M Evans, Scott M LippmanCancer Cell|October 19, 2004
The convergence of cancer prevention and therapy in early-phase clinical drug developmentJames L Abbruzzese, Scott M LippmanCancer Research|March 17, 2006
Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award LectureScott M Lippman, J Jack LeeJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Advances in the biology of lung cancer chemopreventionFred R Hirsch, Scott M LippmanSeminars in Oncology|June 5, 2004
COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancerAnita L Sabichi, Scott M LippmanPageof 36